for the prevention of gastro-enteritis caused by Rotavirus, Gl and non G1 serotypes (G2, G3, G4, G9)

Rotarix contains a live, attenuated human rotavirus that replicates in the small intestine and induces immunity against gastroenteritis

Effect of food: none

patients with known hypersensitivity to Rotarix vaccine or to any of its components; patients with uncorrected congenital malformation of the gastrointestinal tract

Rotarixi is not intended for use in adults

Rotarixi is not intended for use in adults

Loss of appetite, Vomiting, Irritability, Cough, Fever

Rotarix is for oral use only! The vaccination course consists of two doses. The first dose may be administered from the age of 6 weeks. There should be an interval of at least 4 weeks between doses. The vaccination course should be completed by the age of 24 weeks. Reconstitute only with supplied diluent and administer within 24 hours of reconstitution.

Should be stored at 2-8℃